These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28716444)

  • 1. Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine.
    Graser-Loescher G; Schoenhuber A; Ciglenec C; Eberl S; Krupitza G; Mader RM; Jadav SS; Jayaprakash V; Fritzer-Szekeres M; Szekeres T; Saiko P
    Food Chem Toxicol; 2017 Oct; 108(Pt A):53-62. PubMed ID: 28716444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.
    Saiko P; Steinmann MT; Schuster H; Graser G; Bressler S; Giessrigl B; Lackner A; Grusch M; Krupitza G; Bago-Horvath Z; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Phytomedicine; 2015 Jan; 22(1):213-22. PubMed ID: 25636891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
    Saiko P; Ozsvar-Kozma M; Bernhaus A; Jaschke M; Graser G; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Int J Oncol; 2007 Nov; 31(5):1261-6. PubMed ID: 17912455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
    Saiko P; Graser G; Giessrigl B; Lackner A; Grusch M; Krupitza G; Basu A; Sinha BN; Jayaprakash V; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Biochem Pharmacol; 2011 Jan; 81(1):50-9. PubMed ID: 20849828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
    Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
    J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Exp Hematol; 2005 Mar; 33(3):329-35. PubMed ID: 15730856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.
    Sigmond J; Kamphuis JA; Laan AC; Hoebe EK; Bergman AM; Peters GJ
    Biochem Pharmacol; 2007 May; 73(10):1548-57. PubMed ID: 17324380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
    Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
    Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
    Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Fritzer-Szekeres M; Szekeres T
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1541-4. PubMed ID: 15571294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
    Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
    Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
    Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
    Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
    Höchtl T; Horvath Z; Bauer W; Karl D; Saiko P; Elford HL; Fritzer-Szekeres M; Szekeres T
    Life Sci; 2004 Jan; 74(9):1071-80. PubMed ID: 14687648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Murias M; Saiko P; Erker T; Handler N; Madlener S; Jaeger W; Grusch M; Fritzer-Szekeres M; Krupitza G; Szekeres T
    Exp Hematol; 2006 Oct; 34(10):1377-84. PubMed ID: 16982330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives.
    Ertas M; Sahin Z; Bulbul EF; Bender C; Biltekin SN; Berk B; Yurttas L; Nalbur AM; Celik H; Demirayak Ş
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900033. PubMed ID: 31475759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.
    Crona M; Codó P; Jonna VR; Hofer A; Fernandes AP; Tholander F
    Mol Oncol; 2016 Nov; 10(9):1375-1386. PubMed ID: 27511871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
    Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
    Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.
    Kunos CA; Chiu SM; Pink J; Kinsella TJ
    Radiat Res; 2009 Dec; 172(6):666-76. PubMed ID: 19929413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
    Madlener S; Illmer C; Horvath Z; Saiko P; Losert A; Herbacek I; Grusch M; Elford HL; Krupitza G; Bernhaus A; Fritzer-Szekeres M; Szekeres T
    Cancer Lett; 2007 Jan; 245(1-2):156-62. PubMed ID: 16488533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.